StonvexLoading…
StonvexCore line items from GPOR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.42B | $958.13M | $1.79B | $1.33B |
Operating Income | $600.42M | $-236.76M | $974.85M | $543.13M |
Net Income | $427.81M | $-261.39M | $1.47B | $494.70M |
EPS (Diluted) | $21.48 | $-14.72 | $66.46 | $20.32 |
Total Assets | $3.03B | $2.87B | $3.27B | $2.53B |
Total Liabilities | $1.19B | $1.12B | $1.06B | $1.65B |
Cash & Equivalents | $1.81M | $1.47M | $1.93M | $7.26M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 18.80M | 17.80M | 18.30M | 19.10M |